Applied Policy team unites for company retreat
The Applied Policy team convened for a company-wide retreat in October. The three-day event offered an opportunity to recommit to a shared vision and to reunite in person…
Read more
The impact of the Inflation Reduction Act on physicians
Since the passage of the Inflation Reduction Act (IRA) in August, much attention has been paid to its provisions specific to drug pricing. A scaled back version of…
Read more
Nurse practitioners and physician assistants
The story is familiar by now: The adoption of hotly debated legislation dramatically increases healthcare access for millions of Americans and the nation’s healthcare workforce is challenged in…
Read more
MDMA holds 2022 Medical Technology Executive Forum
The Medical Device Manufacturers Association (MDMA) held a virtual meeting on Friday, September 23. Participants included representatives from the Food and Drug Administration (FDA), Centers for Medicare &…
Read more
Medical Inflation
It’s an axiom of healthcare administration: medical inflation outpaces the Consumer Price Index for All Urban Consumers (CPI-U). And figures from the U.S. Bureau of Labor Statistics (BLS)…
Read more
Applied Policy hosts Georgia Healthcare Group
In September, Applied Policy hosted a meeting with members of the Georgia Healthcare Group, a provider of a broad range of healthcare services throughout the country of Georgia.…
Read more
The national coverage determination process
As the United States’ largest payor for healthcare services, the Centers for Medicare & Medicaid Services (CMS) exercises unrivaled potential to shape healthcare markets and health outcomes through…
Read more
Payment considerations for IVD tests
In June, Applied Policy’s diagnostic experts introduced a new series, “IVD Test Reimbursement: Coverage, Coding, and Payment.” For our fourth and final article in the series, we explore…
Read more
Fine-tuning the No Surprises Act
Passed with bipartisan support, signed into law by President Trump, and implemented under the Biden administration, the No Surprises Act (NSA) might seem to have the hallmarks of…
Read more
CMS holds stakeholder call on Medicaid and CHIP continuous enrollment unwinding
On August 24, 2022, the Centers for Medicare & Medicaid Services (CMS) held its fourth monthly webinar about the unwinding of the COVID-19 public health emergency (PHE) flexibilities…
Read more
Applied Policy welcomes Alison Falb to executive team
Applied Policy has welcomed Alison Falb, J.D. as Health Policy Director for Pharmaceuticals, effective August 22. Prior to joining Applied Policy, Alison was a regulatory counsel at the…
Read more
Disparities in diabetic amputations
Among patients with diabetic foot disease, the possibility of losing a foot or leg to amputation can be more frightening than other potential complications of the disease, including…
Read more